TY - JOUR
T1 - 3D cell cultures as prospective models to study extracellular vesicles in cancer
AU - Bordanaba-Florit, Guillermo
AU - Madarieta, Iratxe
AU - Olalde, Beatriz
AU - Falcón-Pérez, Juan M.
AU - Royo, Félix
N1 - Publisher Copyright:
© 2021 by the authors.
PY - 2021/1/15
Y1 - 2021/1/15
N2 - The improvement of culturing techniques to model the environment and physiological conditions surrounding tumors has also been applied to the study of extracellular vesicles (EVs) in cancer research. EVs role is not only limited to cell-to-cell communication in tumor physiology, they are also a promising source of biomarkers, and a tool to deliver drugs and induce antitumoral activity. In the present review, we have addressed the improvements achieved by using 3D culture models to evaluate the role of EVs in tumor progression and the potential applications of EVs in diagnostics and therapeutics. The most employed assays are gel-based spheroids, often utilized to examine the cell invasion rate and angiogenesis markers upon EVs treatment. To study EVs as drug carriers, a more complex multicellular cultures and organoids from cancer stem cell populations have been developed. Such strategies provide a closer response to in vivo physiology observed responses. They are also the best models to understand the complex interactions between different populations of cells and the extracellular matrix, in which tumor-derived EVs modify epithelial or mesenchymal cells to become protumor agents. Finally, the growth of cells in 3D bioreactor-like systems is appointed as the best approach to industrial EVs production, a necessary step toward clinical translation of EVs-based therapy.
AB - The improvement of culturing techniques to model the environment and physiological conditions surrounding tumors has also been applied to the study of extracellular vesicles (EVs) in cancer research. EVs role is not only limited to cell-to-cell communication in tumor physiology, they are also a promising source of biomarkers, and a tool to deliver drugs and induce antitumoral activity. In the present review, we have addressed the improvements achieved by using 3D culture models to evaluate the role of EVs in tumor progression and the potential applications of EVs in diagnostics and therapeutics. The most employed assays are gel-based spheroids, often utilized to examine the cell invasion rate and angiogenesis markers upon EVs treatment. To study EVs as drug carriers, a more complex multicellular cultures and organoids from cancer stem cell populations have been developed. Such strategies provide a closer response to in vivo physiology observed responses. They are also the best models to understand the complex interactions between different populations of cells and the extracellular matrix, in which tumor-derived EVs modify epithelial or mesenchymal cells to become protumor agents. Finally, the growth of cells in 3D bioreactor-like systems is appointed as the best approach to industrial EVs production, a necessary step toward clinical translation of EVs-based therapy.
KW - 3D culture
KW - Cancer
KW - Extracellular vesicles
KW - Therapy
KW - Tumoral cells
UR - http://www.scopus.com/inward/record.url?scp=85099575529&partnerID=8YFLogxK
U2 - 10.3390/cancers13020307
DO - 10.3390/cancers13020307
M3 - Article
AN - SCOPUS:85099575529
SN - 2072-6694
VL - 13
SP - 1
EP - 17
JO - Cancers
JF - Cancers
IS - 2
M1 - 307
ER -